Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Pharmacogenetics and Genomics|February 4, 2010
Functional consequences of nonsynonymous single nucleotide polymorphisms in the CB2 cannabinoid receptorAlex Carrasquer, Nstang M Nebane, Walter M Williams, et al.
International Journal of Pediatric Endocrinology|January 30, 2010
A categorical structure-activity relationship analysis of the developmental toxicity of antithyroid drugsAlbert R Cunningham, C Alex Carrasquer, Donald R Mattison
Anticancer Research|October 4, 2011
Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell linesShahid Qamar, C Alex Carrasquer, Suzanne L Cunningham, et al.
Molecular Vision|April 18, 2006
CB1 cannabinoid receptor-mediated changes of trabecular meshwork cellular propertiesAkhilesh Kumar, Zhao-Hui Song
Biochemical and Biophysical Research Communications|April 25, 2013
Identification of raloxifene as a novel CB2 inverse agonistPritesh Kumar, Zhao-Hui Song
Biochemical and Biophysical Research Communications|November 27, 2013
CB2 cannabinoid receptor is a novel target for third-generation selective estrogen receptor modulators bazedoxifene and lasofoxifenePritesh Kumar, Zhao-Hui Song
Biochemical and Biophysical Research Communications|June 3, 2017
GPR3 and GPR6, novel molecular targets for cannabidiolAlyssa S Laun, Zhao-Hui Song
Biochemical and Biophysical Research Communications|December 11, 2019
Discovery of endogenous inverse agonists for G protein-coupled receptor 6Sarah H Shrader, Zhao-Hui Song
Pageof 6